ANI Pharmaceuticals Inc
Gesloten
SectorGezondheidszorg
82.22 -0.36
Overzicht
Wijziging aandelenprijs
24u
Min
82.04
Max
83.9
Inkomsten | -61K 27M |
|---|---|
Verkoop | -9.6M 237M |
K/W Sectorgemiddelde | 20.609 50.958 |
EPS | 1.68 |
Winstmarge | 11.551 |
Werknemers | 970 |
EBITDA | -20M 57M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +37.81% upside |
Volgende Winsten | 7 aug 2026 |
|---|
Marktkapitalisatie | -41M 1.8B |
|---|---|
Vorige openingsprijs | 82.58 |
Vorige sluitingsprijs | 82.22 |
Nieuwssentiment
By Acuity
50%
50%
146 / 342 Rangschikking in Healthcare
ANI Pharmaceuticals Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.